Skip directly to search
Skip directly to A to Z list
Skip directly to navigation
Skip directly to page options
Skip directly to site content
Start of Search Controls
Search Form Controls
Search The CDC
submit
CDC A-Z Index
MENU
CDC A-Z
SEARCH
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Search Form Controls
Search The CDC
submit
CDC A-Z Index
Public Health Genomics and Precision Health Knowledge Base (v9.0)
PHGKB
About
Public Health Genomics Branch
PHGKB Weekly Horizon Scan
Genomics Precision Health Scan
Advanced Molecular Detection Clips
Non-Genomics Precision Health Scan
CDC-authored Publications Scan
Specialized PHGKB
Cancer PHGKB
Diabetes PHGKB
Economic Evaluation PHGKB
Environmental Health PHGKB
Family Health History PHGKB
Health Equity PHGKB
HLBS-PopOmics
Infectious Diseases PHGKB
Implementation Science PHGKB
Neurological Disorders PHGKB
Pharmacogenomics PHGKB
Primary Immune Deficiency Diseases PHGKB
Rare Diseases PHGKB
Reproductive and Child Health PHGKB
All Databases
COVID-19 GPH (47370)
CDC/NIH Web Information Database (32181)
CDC-Authored Genomics and Precision Health Publications Database (5878)
Precision Health Database (63675)
Tier-Classified Guidelines Database (534)
Pathogen Advanced Molecular Detection Database (26775)
All of Us Reports and Publications Database (676)
Human Genome Epidemiology
Human Genome Epidemiology Literature Finder (226516)
Epigenetic Epidemiology Publications Database (22780)
Release Note
Contact Us
Precision Health Database
Precision Health Database|Search|Public Health Genomics and Precision Health Knowledge Base (PHGKB)
Cancer
Last data update: Apr 25, 2024
. (Total: 63675 Documents since 2012)
All
Cancer
Diabetes
Economic
Equity
Environmental
FHH
HLBS
ID
Implementation
ND
PGx
PI
Rare
RCH
dataset
All
GPH
Non-GPH
Filtered By
:
Select to fine-tune your search
Disease
Gene
Product Type
Category
Year
Previous
Records 1 - 30 (of 122 Records)
Next
Query Trace:
Racial and sex differences in tumor genomics in urothelial carcinoma.
Yaw A Nyame et al. Urol Oncol 2023
Similar articles in PubMed
Assessment of Tumor Mutational Burden and Outcomes in Patients With Diverse Advanced Cancers Treated With Immunotherapy.
Charu Aggarwal et al. JAMA Netw Open 2023 6(5) e2311181
Similar articles in PubMed
A Favorable Benefit-Risk Balance Maybe Expected with the Replication-defective Adenovirus-mediated Interferon Gene Therapy for Cancer Treatment.
Albert Qin et al. Human gene therapy 2023
Similar articles in PubMed
Systematic review of reported association studies of monogenic genes and bladder cancer risk and confirmation analysis in a large population cohort.
Abrar Mian et al. BJUI compass 2023 4(2) 156-163
Similar articles in PubMed
Relative Risk of Bladder and Kidney Cancer in Lynch Syndrome: Systematic Review and Meta-Analysis.
Nassour Anthony-Joe et al. Cancers 2023 15(2)
Similar articles in PubMed
A risk score for the prognosis prediction of the muscle-invasive bladder cancer patients who received gemcitabine plus cisplatin chemotherapy.
Guo Yupeng et al. Aging 2022 14
Similar articles in PubMed
TERT Promoter Mutations as Simple and Non-Invasive Urinary Biomarkers for the Detection of Urothelial Bladder Cancer in a High-Risk Region.
Pakmanesh Hamid et al. International journal of molecular sciences 2022 23(22)
Similar articles in PubMed
Genitourinary manifestations of Lynch syndrome in the urological practice.
Lonati Chiara et al. Asian journal of urology 2022 9(4) 443-450
Similar articles in PubMed
Development and validation of a novel model for predicting the survival of bladder cancer based on ferroptosis-related genes.
Li Lianjun et al. Aging 2022 14
Similar articles in PubMed
Interaction between blood pressure and genetic risk score for bladder cancer, and risk of urothelial carcinoma in men.
Teleka Stanley et al. Scientific reports 2022 12(1) 18336
Similar articles in PubMed
Susceptibility Loci in SLC15A1, UGT1A3, and CWC27 Genes Associated with Bladder Cancer in the Northeast Chinese Population.
Wu Peihong et al. BioMed research international 2022 20222988159
Similar articles in PubMed
Landscape of RB1 alterations in 22,432 Chinese solid tumor patients.
Xu Guanghui et al. Annals of translational medicine 2022 10(16) 885
Similar articles in PubMed
Prevalence of ARID1A Mutations in Cell-Free Circulating Tumor DNA in a Cohort of 71,301 Patients and Association with Driver Co-Alterations.
Kurzrock Razelle et al. Cancers 2022 14(17)
Similar articles in PubMed
Prognostic Role of RNA Expression Molecular Biomarkers in Prostate and Bladder Cancers.
Ahmed Mohamed E et al. European urology focus 2022
Similar articles in PubMed
Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder Cancer.
Pietzak Eugene J et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2022
Similar articles in PubMed
Prevalence of Germline Findings Among Tumors From Cancer Types Lacking Hereditary Testing Guidelines.
Yap Timothy A et al. JAMA network open 2022 5(5) e2213070
Similar articles in PubMed
Association of Pathogenic Variants in Hereditary Cancer Genes With Multiple Diseases.
Zeng Chenjie et al. JAMA oncology 2022
Similar articles in PubMed
Prognostic and Predictive Value of Fibroblast Growth Factor Receptor Alterations in High-grade Non-muscle-invasive Bladder Cancer Treated with and Without Bacillus Calmette-Guérin Immunotherapy.
Mayr Roman et al. European urology 2022
Similar articles in PubMed
Detection of Cancer Mutations by Urine Liquid Biopsy as a Potential Tool in the Clinical Management of Bladder Cancer Patients.
Ibrahim Nurul Khalida et al. Cancers 2022 14(4)
Similar articles in PubMed
A 7-gene signature predicts the prognosis of patients with bladder cancer.
Tang Fucai et al. BMC urology 2022 22(1) 8
Similar articles in PubMed
Development and validation of Pyroptosis‑related lncRNAs prediction model for bladder cancer.
Lia Thongher et al. Bioscience reports 2022
Similar articles in PubMed
Multi-Omics analysis identifies a lncRNA-related prognostic signature to predict bladder cancer recurrence.
Xu Zhipeng et al. Bioengineered 2021
Similar articles in PubMed
Identification of Lymph Node Metastasis-Related Key Genes and Prognostic Risk Model in Bladder Cancer by Co-Expression Analysis.
Luo Cheng et al. Frontiers in molecular biosciences 2021 8633299
Similar articles in PubMed
Biomarker approach harnessed in trials of personalized medicine for bladder cancer
N Dizman et al, Nature Medicine, May 3, 2021
Genetic Differences Between Bladder and Upper Urinary Tract Carcinoma: Implications for Therapy.
Sfakianos John P et al. European urology oncology 2020 Dec
Similar articles in PubMed
A TP53-based immune prognostic model for muscle-invasive bladder cancer.
Li Hongyan et al. Aging 2020 Dec 12
Similar articles in PubMed
Autophagy-related long noncoding RNAs can predict prognosis in patients with bladder cancer.
Lai Cong et al. Aging 2020 Nov 12
Similar articles in PubMed
Targeted Molecular Therapeutics for Bladder Cancer-A New Option beyond the Mixed Fortunes of Immune Checkpoint Inhibitors?
Bednova Olga et al. International journal of molecular sciences 2020 Oct 21(19)
Similar articles in PubMed
Clinical Validation of a Urine Test (Uromonitor-V2 ® ) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients.
Sieverink Caroline A et al. Diagnostics (Basel, Switzerland) 2020 Sep 10(10)
Similar articles in PubMed
Extensive heterogeneity in somatic mutation and selection in the human bladder.
Lawson Andrew R J et al. Science (New York, N.Y.) 2020 Oct 370(6512) 75-82
Similar articles in PubMed
File Formats Help:
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?
Adobe PDF file
Microsoft PowerPoint file
Microsoft Word file
Microsoft Excel file
Audio/Video file
Apple Quicktime file
RealPlayer file
Text file
Zip Archive file
SAS file
ePub file
Page last reviewed:
Feb 1, 2024
Page last updated:
Apr 25, 2024
Content source:
Public Health Genomics Branch in the Division of Blood Disorders and Public Health Genomics
,
National Center on Birth Defects and Developmental Disabilities
TOP